290650 Stock Chart & Stats
₩56200.00
-₩6,900.00(-10.94%)
―
--
Day’s Range― - ―
52-Week Range₩29,100.00 - ₩125,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)335.47K
Market Cap
₩1.52T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,969,704
10 Day Avg. Volume183,126
30 Day Avg. Volume335,467
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,072.25
Revenue Forecast (FY)₩173.53B
290650 FAQ
What was L&C BIO Co., Ltd.’s price range in the past 12 months?
L&C BIO Co., Ltd. lowest stock price was ₩29100.00 and its highest was ₩125000.00 in the past 12 months.
What is L&C BIO Co., Ltd.’s market cap?
L&C BIO Co., Ltd.’s market cap is ₩1.52T.
When is L&C BIO Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were L&C BIO Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is L&C BIO Co., Ltd. overvalued?
According to Wall Street analysts L&C BIO Co., Ltd.’s price is currently Undervalued.
Does L&C BIO Co., Ltd. pay dividends?
L&C BIO Co., Ltd. does not currently pay dividends.
What is L&C BIO Co., Ltd.’s EPS estimate?
L&C BIO Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does L&C BIO Co., Ltd. have?
L&C BIO Co., Ltd. has 26,969,704 shares outstanding.
What happened to L&C BIO Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of L&C BIO Co., Ltd.?
Currently, no hedge funds are holding shares in KR:290650
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GC Biopharma Corp.
―
Celltrion Pharm Inc.
―
Seegene, Inc.
―
Chong Kun Dang Pharmaceutical Corp.
―
HK inno.N Corporation
―